Literature DB >> 10445022

Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2.

H Lee1, A H Trainer, L S Friedman, F C Thistlethwaite, M J Evans, B A Ponder, A R Venkitaraman.   

Abstract

The murine Brca2 gene encodes a nuclear protein implicated in DNA repair. Brca2 behaves as a tumor suppressor, but paradoxically, its truncation causes proliferative arrest and spontaneous chromosomal damage. Here, we report that inactivation of cell cycle checkpoints responsive to mitotic spindle disruption, by mutant forms of p53 or Bub1, relieves growth arrest and initiates neoplastic transformation in primary cells homozygous for truncated Brca2. Tumors from Brca2-deficient animals exhibit dysfunction of the spindle assembly checkpoint, accompanied by mutations in p53, Bub1, and Mad3L. The chromosomal aberrations precipitated by Brca2 truncation can be suppressed by mutant forms of Bub1 and p53. Thus, inactivating mutations in mitotic checkpoint genes likely cooperate with BRCA2 deficiency in the pathogenesis of inherited breast cancer, with important implications for treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10445022     DOI: 10.1016/s1097-2765(00)80182-3

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  43 in total

1.  Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining.

Authors:  F Xia; D G Taghian; J S DeFrank; Z C Zeng; H Willers; G Iliakis; S N Powell
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1.

Authors:  Marina Cotsiki; Rowena L Lock; Yuan Cheng; Grace L Williams; Jean Zhao; David Perera; Raimundo Freire; Alan Entwistle; Erica A Golemis; Thomas M Roberts; Parmjit S Jat; Ole V Gjoerup
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

3.  EXO1-dependent single-stranded DNA at telomeres activates subsets of DNA damage and spindle checkpoint pathways in budding yeast yku70Delta mutants.

Authors:  Laura Maringele; David Lydall
Journal:  Genes Dev       Date:  2002-08-01       Impact factor: 11.361

4.  Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2.

Authors:  Gong Yang; Bin Chang; Fan Yang; Xiaoqing Guo; Kathy Qi Cai; Xue Sherry Xiao; Huamin Wang; Subrata Sen; Mien-Chie Hung; Gordon B Mills; Sandy Chang; Asha S Multani; Imelda Mercado-Uribe; Jinsong Liu
Journal:  Clin Cancer Res       Date:  2010-04-27       Impact factor: 12.531

Review 5.  The role of BRCA mutation testing in determining breast cancer therapy.

Authors:  Alison H Trainer; Craig R Lewis; Kathy Tucker; Bettina Meiser; Michael Friedlander; Robyn L Ward
Journal:  Nat Rev Clin Oncol       Date:  2010-11-09       Impact factor: 66.675

6.  Mitotic checkpoint function in the formation of gross chromosomal rearrangements in Saccharomyces cerevisiae.

Authors:  Kyungjae Myung; Stephanie Smith; Richard D Kolodner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-28       Impact factor: 11.205

7.  Functional assays for classification of BRCA2 variants of uncertain significance.

Authors:  Daniel J Farrugia; Mukesh K Agarwal; Vernon S Pankratz; Amie M Deffenbaugh; Dmitry Pruss; Cynthia Frye; Linda Wadum; Kiley Johnson; Jennifer Mentlick; Sean V Tavtigian; David E Goldgar; Fergus J Couch
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

8.  Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein.

Authors:  Mikhail Lomonosov; Shubha Anand; Mahesh Sangrithi; Rachel Davies; Ashok R Venkitaraman
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

9.  A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic background.

Authors:  Dale O Cowley; Ginger W Muse; Terry Van Dyke
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

10.  BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers.

Authors:  Y-K Lee; E Choi; M A Kim; P-G Park; N-H Park; H Lee
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.